Lupin earnings outperform Street expectations, to stay our top pick: Kirit Gogri, Quant Broking

In a chat with ET Now, Kirit Gogri, Senior VP, Quant Broking Pvt Ltd, shares his stock views on Lupin. Excerpts:

ET Now: What is the sense that you are getting about the stock price move? At Rs 904, how would you rate this counter?

Kirit Gogri: In fact, it is one of our top buys and it continues to remain so and I see significant upsides from the current levels.

ET Now: What is your 12-month price target?

Kirit Gogri: We have a price target of Rs 1044 currently, based on our FY15 numbers.

ET Now: I read about what Lupin is doing in Japan. The Japanese market is getting extremely competitive and in fact, some Indian pharma companies have already indicated that they do not want to do business in Japan.

Kirit Gogri: Yes, Japan is a slightly different market than Europe and the US, but looking at Lupin’s position in that market, I believe Lupin has a strong visibility, though they have short term issues.